top of page
Offered by:
Powered by:
Hosted by:
ACS Bright Edge, supported by AbbVie, LH Capital, and Research Bridge Partners are sponsoring to award 1 Golden Ticket at BioLabs Pegasus Park.
​
Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate early-stage oncology companies with promising new therapies, preferably with platforms that can be applied to multiple targets, that could benefit patients with hematologic and solid tumor malignancies.
Application
Benefits
Golden Ticket Benefits
Eligibility Snapshot
ACS Bright Edge, AbbVie, LH Capital, and Research Bridge Partners are looking for early-stage biotech companies that fit the following criteria:
Early Stage
Oncology therapeutics
Able to take space at BioLabs Pegasus Park
Eligibility
Focus Areas
Early-stage oncology companies with promising new therapies, preferably with platforms that can be applied to multiple targets, that could benefit patients with hematologic and solid tumor malignancies. Areas of interest include :
App Process
The Application Process
01
Submit applications by
January 17, 2025
02
A subset of applications will be identified as finalist by the contest judges by
February 10, 2025
03
Finalists will present their company & scientific concept at Pegasus Park
on March 11, 2025
04
1 award will be granted
Good luck!
Judging criteria
Contact Us
If you have any questions regarding this competition, contact
farnaz.bakhshi@cancer.org​​
​
If you have any questions about BioLabs, contact
bottom of page